Federal Register Notice: FDA will hold a meeting of the Endocrinologic and Metabolic Drugs Advisory Committee and the Advisory Committee for Pharmaceutical Science 10/4, from 8 a.m. to 5 p.m. at the Hilton, The Ballrooms, 620 Perry Pkwy, Gaithersburg, MD. The joint committee will discuss FDA's efforts to assess the product quality of currently marketed levothyroxine sodium drug products. Contact Victoria Ferretti-Aceto, (301) 827-7001. To view this notice, click here.